Matthias Hoepting

Regensburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Plasma lipid alterations in thrombosis and antiphospholipid syndrome - a differentiating lipid plasma composite score.

Plasma lipid alterations in thrombosis and antiphospholipid syndrome - a differentiating lipid plasma composite score.

Journal: Journal of lipid research

Published: April 02, 2026

"The antibiotic paradox" in allogeneic stem cell transplantation.

"The antibiotic paradox" in allogeneic stem cell transplantation.

Journal: Bone marrow transplantation

Published: April 28, 2025

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Journal: Blood

Published: March 28, 2025

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Journal: Blood

Published: March 28, 2025

Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo.

Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 20, 2024

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study.

Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study.

Journal: Research and practice in thrombosis and haemostasis

Published: July 03, 2024

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis.

Journal: Blood advances

Published: November 01, 2023

Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.

Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.

Journal: Haematologica

Published: October 31, 2023

A Day 14 Endpoint for Acute GVHD Clinical Trials.

A Day 14 Endpoint for Acute GVHD Clinical Trials.

Journal: Transplantation and cellular therapy

Published: October 03, 2023

Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

Effective treatment of low-risk acute GVHD with itacitinib monotherapy.

Journal: Blood

Published: June 16, 2022

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Journal: Acta haematologica

Published: October 03, 2021

GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.

GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.

Journal: Frontiers in immunology

Published: August 04, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026